238 related articles for article (PubMed ID: 19943215)
21. American Association for Cancer Research--100th Annual Meeting. New therapeutic developments: part 1. 18-22 April 2009, Denver, CO, USA.
Gale S; McGee V; Lee W
IDrugs; 2009 Jun; 12(6):331-4. PubMed ID: 19517308
[No Abstract] [Full Text] [Related]
22. Americas Antibody Congress 2009. 21-23 September 2009, Washington DC, USA.
Reyes CL
IDrugs; 2009 Nov; 12(11):692-4. PubMed ID: 19844854
[TBL] [Abstract][Full Text] [Related]
23. ADMET--Fifth Annual SMi Conference.
Comer JE
IDrugs; 2010 Sep; 13(9):610-4. PubMed ID: 20799141
[TBL] [Abstract][Full Text] [Related]
24. RNAi for Developing Targeted Therapeutics--CHI's Third Annual Meeting.
Plane G
IDrugs; 2010 Jan; 13(1):20-2. PubMed ID: 20024842
[TBL] [Abstract][Full Text] [Related]
25. AIDS 2010--XVIII International AIDS Conference.
Desimmie BA
IDrugs; 2010 Sep; 13(9):622-5. PubMed ID: 20799144
[TBL] [Abstract][Full Text] [Related]
26. Coronary Artery Disease - Eighth International Congress. From prevention to intervention.
Wong NC
IDrugs; 2009 Dec; 12(12):742-6. PubMed ID: 19943213
[TBL] [Abstract][Full Text] [Related]
27. The British Pharmaceutical Conference 2009. 6-9 September 2009, Manchester, UK.
Uchegbu I
IDrugs; 2009 Nov; 12(11):683-5. PubMed ID: 19844851
[TBL] [Abstract][Full Text] [Related]
28. Highlights in experimental therapeutics.
Burger AM
Cancer Lett; 2007 Jan; 245(1-2):11-21. PubMed ID: 16647200
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers in Clinical Trials--SMi Conference. 23-24 September 2009, London, UK.
Walker G
IDrugs; 2009 Nov; 12(11):673-4. PubMed ID: 19844848
[TBL] [Abstract][Full Text] [Related]
30. Ion Channels as Therapeutic Targets--CHI's Fourth Annual Conference.
Thorneloe KS
IDrugs; 2010 Jan; 13(1):16-9. PubMed ID: 20024841
[TBL] [Abstract][Full Text] [Related]
31. American Society of Clinical Oncology--46th annual meeting.
Al-Shamahi A; Murch L; Kirkham K
IDrugs; 2010 Aug; 13(8):506-9. PubMed ID: 20721815
[TBL] [Abstract][Full Text] [Related]
32. Terrapinn's world influenza congress Europe 2009. Part 2.
Veryard C
IDrugs; 2010 Feb; 13(2):78-9. PubMed ID: 20127556
[TBL] [Abstract][Full Text] [Related]
33. Proteasome inhibition in multiple myeloma.
Kropff M; Bisping G; Wenning D; Berdel WE; Kienast J
Eur J Cancer; 2006 Jul; 42(11):1623-39. PubMed ID: 16820291
[TBL] [Abstract][Full Text] [Related]
34. The role of proteasome in malignant diseases.
Moran E; Nencioni A
J BUON; 2007 Sep; 12 Suppl 1():S95-9. PubMed ID: 17935285
[TBL] [Abstract][Full Text] [Related]
35. Proteasome inhibition and multiple myeloma.
Kanagasabaphy P; Morgan GJ; Davies FE
Curr Opin Investig Drugs; 2007 Jun; 8(6):447-51. PubMed ID: 17621873
[TBL] [Abstract][Full Text] [Related]
36. AACR-NCI-EORTC International Conference 2009.
Awada A; Lacombe D
Expert Rev Anticancer Ther; 2010 Mar; 10(3):319-20. PubMed ID: 20214512
[TBL] [Abstract][Full Text] [Related]
37. Metastasis and the Tumor Microenvironment: A Joint Metastasis Research Society-AACR Conference - Research on Metastasis: part 2.
Eccles SA
IDrugs; 2010 Nov; 13(11):768-71. PubMed ID: 21046523
[TBL] [Abstract][Full Text] [Related]
38. CHI's Fourth Annual Drug Discovery Chemistry Conference. Kinase inhibitor chemistry: charting the chemical space. 7-8 April 2009, San Diego, CA, USA.
Seneci P
IDrugs; 2009 Jun; 12(6):358-62. PubMed ID: 19517315
[No Abstract] [Full Text] [Related]
39. European Neuroscience--Seventh Biennial FENS Forum.
Hannan AJ
IDrugs; 2010 Sep; 13(9):607-9. PubMed ID: 20799140
[TBL] [Abstract][Full Text] [Related]
40. Society for biomolecular sciences - 16th annual conference & exhibition - advancing the science of drug discovery.
Napper AD
IDrugs; 2010 Jun; 13(6):372-5. PubMed ID: 20506057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
